<i>STAT1</i> Gain-of-Function Variants Drive Altered T Cell Prevalence, Metabolism, and Heightened IL-6 Sensitivity
Saara Kaviany(Vanderbilt University Medical Center), Jeffrey C. Rathmell(University of Chicago), Jonathan M. Irish(Vanderbilt University), Debolanle O. Dahunsi(Vanderbilt University Medical Center), James A. Connelly(Michigan Center for Translational Pathology), Samuel Schaefer, Daniel E. Dulek(Vanderbilt University Medical Center), Todd Bartkowiak(Vanderbilt University), Yasmin Khan(Vanderbilt University Medical Center), Madeline Hayes(Vanderbilt University)
Cited by 2
Related Papers
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717